Kaposi Sarcoma Associated with Human Immunodeficiency Syndrome: A Case Report
Article Sidebar
Main Article Content
Abstract
Kaposi Sarcoma is a neoplasm described in four distinct types, with the epidemic form being the most prevalent among individuals living with HIV. This form is characterized by a more aggressive disease presentation, affecting mucous membranes and visceral organs. We report the case of a 42-year-old male patient who sought medical care due to cutaneous lesions, initially diagnosed as psoriasis. Subsequently, the lesions worsened, and a biopsy was performed, confirming the diagnosis of Kaposi Sarcoma. Additional examinations later revealed HIV and CMV infections, leading to the initiation of antiretroviral therapy (ART). Shortly thereafter, the patient was hospitalized with febrile consumptive syndrome and remained hospitalized for 32 days for symptom control and remission. It is important to recognize the clinical presentation of patients in order to establish an earlier diagnosis of Kaposi Sarcoma, thereby enabling the prompt initiation of specific treatment for the condition.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their articles and grant the journal the right of first publication under the Creative Commons Attribution (CC BY) license, which allows others to share and adapt the work with proper attribution.
References
Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: Our current understanding of its diagnosis, treatment and pathop-hysiology. World J Psychiatry. 2016 Dec 22;6(4):391-398. doi: 10.5498/wjp.v6.i4.391.
Palich R, Makinson A, Veyri M, Guihot A, Valantin MA, Brégigeon-Ronot S, Poizot-Martin I, Solas C, Grabar S, Martin-Blondel G, Spano JP. Kaposi's Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition. Cancers (Basel). 2021 Nov 15;13(22):5702. doi: 10.3390/cancers13225702. PMID: 34830857; PMCID: PMC8616070. https://pmc.ncbi.nlm.nih.gov/articles/PMC8616070/.
Karabajakian A, Ray-Coquard I, Blay JY. Molecular Mechanisms of Kaposi Sarcoma Development. Cancers (Basel). 2022 Apr 7;14(8):1869. doi: 10.3390/cancers14081869. PMID: 35454776; PMCID: PMC9030761. https://pmc.ncbi.nlm.nih.gov/articles/PMC9030761/.
Mangusan RF, Ekwede I, Widell A. CE: HIV-Associated Kaposi Sarcoma in the Combination Antiretroviral Therapy Era. Am J Nurs. 2022 Dec 1;122(12):32-40. doi: 10.1097/01.NAJ.0000901848.07128.92. PMID: 36321823; PMCID: PMC9671845. https://pmc.ncbi.nlm.nih.gov/articles/PMC9671845/.
Dittmer DP, Damania B. Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update. Cancer Treatment and Research. 2019;177:63–80. doi:10.1007/978-3-030-03502-0_3. https://pubmed.ncbi.nlm.nih.gov/30523621/
Grabar S, Costagliola D. Epidemiology of Kaposi's Sarcoma. Cancers (Basel). 2021 Nov 14;13(22):5692. doi: 10.3390/cancers13225692. PMID: 34830846; PMCID: PMC8616388. https://pmc.ncbi.nlm.nih.gov/articles/PMC8616388/.
Conselho Nacional de Saúde (BR). Resolução n° 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamen-tadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção I:59.
Schneider JW, Dittmer DP. Diagnosis and Treatment of Kaposi Sarcoma. American Journal of Clinical Dermatology. 2017;18(4):529-539. doi:10.1007/s40257-017-0270-4. https://pmc.ncbi.nlm.nih.gov/articles/PMC5509489/.
Gonçalves PH, Uldrick TS, Yarchoan R. HIV-associated Kaposi sarcoma and related diseases. AIDS (London, England). 2017;31(14):1903–1916. doi:10.1097/QAD.0000000000001567. https://pubmed.ncbi.nlm.nih.gov/28609402/.
Ramaswami R et al. Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on. Journal of Clinical Oncology. 2022;40(3):294-306. doi:10.1200/JCO.21.02040. https://pmc.ncbi.nlm.nih.gov/articles/PMC8769148/.